دانلود کتاب Capitalizing a Cure: How Finance Controls the Price and Value of Medicines

فهرست مطالب :

Cover
Title
Copyright
Contents
Chronology of Key Events
Preface
Introduction
Risk, Value, and the Politics of Justification in the Drug Affordability Crisis
Diagnostic Blind Spots in the Price of a Cure
The Missing Diagnosis: Financialization
Opening the Black Box of Price and Value: Capital, Assets, and Power
A Sociological Account: The Case of Sofosbuvir-Based Treatments
Chapter Outlines
1. Capitalizing Science
Overcoming a Technological Hurdle: The Replicon Tool and an Entrepreneurial State
The Triple Helix: Public and Private Science in the Launch of Pharmasset
Sofosbuvir as an Asset and a Relay Race of Financialized Capital
Pharm(asset)
2. Capitalizing Drugs
Life Science amid Shareholder Power
Chasing the Golden Snitch, and a Hepatitis C Gold Rush
The Cannibalizing Company: Following Gilead’s Hepatitis C Money
From R&D to M&A and Buybacks
3. Capitalizing Health
Health as a Financial Asset: Setting and Justifying a $1,000-a-day Price for a Cure
Rationing versus Public Health: The Politics of Value and the Crisis of Treatment Access
The Patient Cliff: The Limits of a Cure as an Asset
Pharma(value)
4. From Financialization to Public Purpose for Health
When Medicines are Financialized: Mechanisms, Mystifications, and Outcomes
Toward a Public-Purpose System
Conclusion
Acknowledgments
Appendix
Notes
References
Index